Report Overview
This report provides a deep insight into the global Adoptive Cell Transfer Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Adoptive Cell Transfer Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Adoptive Cell Transfer Therapy market in any manner.
Global Adoptive Cell Transfer Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Athenex
Xiangxue Pharmaceutical (Xiangxue Precision)
Hengrui Yuanzheng
Eureka Therapeutics
WuXi Juno
Shenzhen Inno Immunity
Shenzhen Binde Bio
Kerui Bio
Adaptimmune
Altor Bioscience Corporation
Cellectis
Takara Bio
Unum Therapeutics
Market Segmentation (by Type)
NK
LAK
DC
CIK
CTL
TIL
TCR-T
CAR-T
Market Segmentation (by Application)
Acute Lymphocytic Leukemia
NHL
Melanoma
Bladder Cancer
Lung Cancer
Head and Neck Cancer
Multiple Myeloma
Other
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Adoptive Cell Transfer Therapy Market
? Overview of the regional outlook of the Adoptive Cell Transfer Therapy Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Adoptive Cell Transfer Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Adoptive Cell Transfer Therapy
1.2 Key Market Segments
1.2.1 Adoptive Cell Transfer Therapy Segment by Type
1.2.2 Adoptive Cell Transfer Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Adoptive Cell Transfer Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Adoptive Cell Transfer Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Adoptive Cell Transfer Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Adoptive Cell Transfer Therapy Market Competitive Landscape
3.1 Global Adoptive Cell Transfer Therapy Sales by Manufacturers (2019-2024)
3.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Adoptive Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Adoptive Cell Transfer Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Adoptive Cell Transfer Therapy Sales Sites, Area Served, Product Type
3.6 Adoptive Cell Transfer Therapy Market Competitive Situation and Trends
3.6.1 Adoptive Cell Transfer Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adoptive Cell Transfer Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Adoptive Cell Transfer Therapy Industry Chain Analysis
4.1 Adoptive Cell Transfer Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Adoptive Cell Transfer Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Adoptive Cell Transfer Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adoptive Cell Transfer Therapy Sales Market Share by Type (2019-2024)
6.3 Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Adoptive Cell Transfer Therapy Price by Type (2019-2024)
7 Adoptive Cell Transfer Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adoptive Cell Transfer Therapy Market Sales by Application (2019-2024)
7.3 Global Adoptive Cell Transfer Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Adoptive Cell Transfer Therapy Sales Growth Rate by Application (2019-2024)
8 Adoptive Cell Transfer Therapy Market Segmentation by Region
8.1 Global Adoptive Cell Transfer Therapy Sales by Region
8.1.1 Global Adoptive Cell Transfer Therapy Sales by Region
8.1.2 Global Adoptive Cell Transfer Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Adoptive Cell Transfer Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adoptive Cell Transfer Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adoptive Cell Transfer Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adoptive Cell Transfer Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adoptive Cell Transfer Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis AG
9.1.1 Novartis AG Adoptive Cell Transfer Therapy Basic Information
9.1.2 Novartis AG Adoptive Cell Transfer Therapy Product Overview
9.1.3 Novartis AG Adoptive Cell Transfer Therapy Product Market Performance
9.1.4 Novartis AG Business Overview
9.1.5 Novartis AG Adoptive Cell Transfer Therapy SWOT Analysis
9.1.6 Novartis AG Recent Developments
9.2 Kite Pharma
9.2.1 Kite Pharma Adoptive Cell Transfer Therapy Basic Information
9.2.2 Kite Pharma Adoptive Cell Transfer Therapy Product Overview
9.2.3 Kite Pharma Adoptive Cell Transfer Therapy Product Market Performance
9.2.4 Kite Pharma Business Overview
9.2.5 Kite Pharma Adoptive Cell Transfer Therapy SWOT Analysis
9.2.6 Kite Pharma Recent Developments
9.3 Pfizer
9.3.1 Pfizer Adoptive Cell Transfer Therapy Basic Information
9.3.2 Pfizer Adoptive Cell Transfer Therapy Product Overview
9.3.3 Pfizer Adoptive Cell Transfer Therapy Product Market Performance
9.3.4 Pfizer Adoptive Cell Transfer Therapy SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Juno Therapeutics
9.4.1 Juno Therapeutics Adoptive Cell Transfer Therapy Basic Information
9.4.2 Juno Therapeutics Adoptive Cell Transfer Therapy Product Overview
9.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.4.4 Juno Therapeutics Business Overview
9.4.5 Juno Therapeutics Recent Developments
9.5 Celgene Corporation
9.5.1 Celgene Corporation Adoptive Cell Transfer Therapy Basic Information
9.5.2 Celgene Corporation Adoptive Cell Transfer Therapy Product Overview
9.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Product Market Performance
9.5.4 Celgene Corporation Business Overview
9.5.5 Celgene Corporation Recent Developments
9.6 CARsgen Therapeutics
9.6.1 CARsgen Therapeutics Adoptive Cell Transfer Therapy Basic Information
9.6.2 CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Overview
9.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.6.4 CARsgen Therapeutics Business Overview
9.6.5 CARsgen Therapeutics Recent Developments
9.7 Sorrento Therapeutics
9.7.1 Sorrento Therapeutics Adoptive Cell Transfer Therapy Basic Information
9.7.2 Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Overview
9.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.7.4 Sorrento Therapeutics Business Overview
9.7.5 Sorrento Therapeutics Recent Developments
9.8 Legend Biotech
9.8.1 Legend Biotech Adoptive Cell Transfer Therapy Basic Information
9.8.2 Legend Biotech Adoptive Cell Transfer Therapy Product Overview
9.8.3 Legend Biotech Adoptive Cell Transfer Therapy Product Market Performance
9.8.4 Legend Biotech Business Overview
9.8.5 Legend Biotech Recent Developments
9.9 Atara Biotherapeutics
9.9.1 Atara Biotherapeutics Adoptive Cell Transfer Therapy Basic Information
9.9.2 Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Overview
9.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.9.4 Atara Biotherapeutics Business Overview
9.9.5 Atara Biotherapeutics Recent Developments
9.10 Aurora Biopharma
9.10.1 Aurora Biopharma Adoptive Cell Transfer Therapy Basic Information
9.10.2 Aurora Biopharma Adoptive Cell Transfer Therapy Product Overview
9.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Product Market Performance
9.10.4 Aurora Biopharma Business Overview
9.10.5 Aurora Biopharma Recent Developments
9.11 Autolus Therapeutics PLC
9.11.1 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Basic Information
9.11.2 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Overview
9.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Market Performance
9.11.4 Autolus Therapeutics PLC Business Overview
9.11.5 Autolus Therapeutics PLC Recent Developments
9.12 Bluebird
9.12.1 Bluebird Adoptive Cell Transfer Therapy Basic Information
9.12.2 Bluebird Adoptive Cell Transfer Therapy Product Overview
9.12.3 Bluebird Adoptive Cell Transfer Therapy Product Market Performance
9.12.4 Bluebird Business Overview
9.12.5 Bluebird Recent Developments
9.13 Carina Biotech
9.13.1 Carina Biotech Adoptive Cell Transfer Therapy Basic Information
9.13.2 Carina Biotech Adoptive Cell Transfer Therapy Product Overview
9.13.3 Carina Biotech Adoptive Cell Transfer Therapy Product Market Performance
9.13.4 Carina Biotech Business Overview
9.13.5 Carina Biotech Recent Developments
9.14 Athenex
9.14.1 Athenex Adoptive Cell Transfer Therapy Basic Information
9.14.2 Athenex Adoptive Cell Transfer Therapy Product Overview
9.14.3 Athenex Adoptive Cell Transfer Therapy Product Market Performance
9.14.4 Athenex Business Overview
9.14.5 Athenex Recent Developments
9.15 Xiangxue Pharmaceutical (Xiangxue Precision)
9.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Basic Information
9.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Overview
9.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Market Performance
9.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
9.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Developments
9.16 Hengrui Yuanzheng
9.16.1 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Basic Information
9.16.2 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Overview
9.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Market Performance
9.16.4 Hengrui Yuanzheng Business Overview
9.16.5 Hengrui Yuanzheng Recent Developments
9.17 Eureka Therapeutics
9.17.1 Eureka Therapeutics Adoptive Cell Transfer Therapy Basic Information
9.17.2 Eureka Therapeutics Adoptive Cell Transfer Therapy Product Overview
9.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.17.4 Eureka Therapeutics Business Overview
9.17.5 Eureka Therapeutics Recent Developments
9.18 WuXi Juno
9.18.1 WuXi Juno Adoptive Cell Transfer Therapy Basic Information
9.18.2 WuXi Juno Adoptive Cell Transfer Therapy Product Overview
9.18.3 WuXi Juno Adoptive Cell Transfer Therapy Product Market Performance
9.18.4 WuXi Juno Business Overview
9.18.5 WuXi Juno Recent Developments
9.19 Shenzhen Inno Immunity
9.19.1 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Basic Information
9.19.2 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Overview
9.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Market Performance
9.19.4 Shenzhen Inno Immunity Business Overview
9.19.5 Shenzhen Inno Immunity Recent Developments
9.20 Shenzhen Binde Bio
9.20.1 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Basic Information
9.20.2 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Overview
9.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Market Performance
9.20.4 Shenzhen Binde Bio Business Overview
9.20.5 Shenzhen Binde Bio Recent Developments
9.21 Kerui Bio
9.21.1 Kerui Bio Adoptive Cell Transfer Therapy Basic Information
9.21.2 Kerui Bio Adoptive Cell Transfer Therapy Product Overview
9.21.3 Kerui Bio Adoptive Cell Transfer Therapy Product Market Performance
9.21.4 Kerui Bio Business Overview
9.21.5 Kerui Bio Recent Developments
9.22 Adaptimmune
9.22.1 Adaptimmune Adoptive Cell Transfer Therapy Basic Information
9.22.2 Adaptimmune Adoptive Cell Transfer Therapy Product Overview
9.22.3 Adaptimmune Adoptive Cell Transfer Therapy Product Market Performance
9.22.4 Adaptimmune Business Overview
9.22.5 Adaptimmune Recent Developments
9.23 Altor Bioscience Corporation
9.23.1 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Basic Information
9.23.2 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Overview
9.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Market Performance
9.23.4 Altor Bioscience Corporation Business Overview
9.23.5 Altor Bioscience Corporation Recent Developments
9.24 Cellectis
9.24.1 Cellectis Adoptive Cell Transfer Therapy Basic Information
9.24.2 Cellectis Adoptive Cell Transfer Therapy Product Overview
9.24.3 Cellectis Adoptive Cell Transfer Therapy Product Market Performance
9.24.4 Cellectis Business Overview
9.24.5 Cellectis Recent Developments
9.25 Takara Bio
9.25.1 Takara Bio Adoptive Cell Transfer Therapy Basic Information
9.25.2 Takara Bio Adoptive Cell Transfer Therapy Product Overview
9.25.3 Takara Bio Adoptive Cell Transfer Therapy Product Market Performance
9.25.4 Takara Bio Business Overview
9.25.5 Takara Bio Recent Developments
9.26 Unum Therapeutics
9.26.1 Unum Therapeutics Adoptive Cell Transfer Therapy Basic Information
9.26.2 Unum Therapeutics Adoptive Cell Transfer Therapy Product Overview
9.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.26.4 Unum Therapeutics Business Overview
9.26.5 Unum Therapeutics Recent Developments
10 Adoptive Cell Transfer Therapy Market Forecast by Region
10.1 Global Adoptive Cell Transfer Therapy Market Size Forecast
10.2 Global Adoptive Cell Transfer Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adoptive Cell Transfer Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Adoptive Cell Transfer Therapy Market Size Forecast by Region
10.2.4 South America Adoptive Cell Transfer Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adoptive Cell Transfer Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Adoptive Cell Transfer Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Adoptive Cell Transfer Therapy by Type (2025-2030)
11.1.2 Global Adoptive Cell Transfer Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Adoptive Cell Transfer Therapy by Type (2025-2030)
11.2 Global Adoptive Cell Transfer Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Adoptive Cell Transfer Therapy Sales (K Units) Forecast by Application
11.2.2 Global Adoptive Cell Transfer Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adoptive Cell Transfer Therapy Market Size Comparison by Region (M USD)
Table 5. Global Adoptive Cell Transfer Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Adoptive Cell Transfer Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Adoptive Cell Transfer Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Adoptive Cell Transfer Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Transfer Therapy as of 2022)
Table 10. Global Market Adoptive Cell Transfer Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Adoptive Cell Transfer Therapy Sales Sites and Area Served
Table 12. Manufacturers Adoptive Cell Transfer Therapy Product Type
Table 13. Global Adoptive Cell Transfer Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Adoptive Cell Transfer Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Adoptive Cell Transfer Therapy Market Challenges
Table 22. Global Adoptive Cell Transfer Therapy Sales by Type (K Units)
Table 23. Global Adoptive Cell Transfer Therapy Market Size by Type (M USD)
Table 24. Global Adoptive Cell Transfer Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Adoptive Cell Transfer Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Adoptive Cell Transfer Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Adoptive Cell Transfer Therapy Market Size Share by Type (2019-2024)
Table 28. Global Adoptive Cell Transfer Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Adoptive Cell Transfer Therapy Sales (K Units) by Application
Table 30. Global Adoptive Cell Transfer Therapy Market Size by Application
Table 31. Global Adoptive Cell Transfer Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Adoptive Cell Transfer Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Adoptive Cell Transfer Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Adoptive Cell Transfer Therapy Market Share by Application (2019-2024)
Table 35. Global Adoptive Cell Transfer Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Adoptive Cell Transfer Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Adoptive Cell Transfer Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Adoptive Cell Transfer Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Adoptive Cell Transfer Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Adoptive Cell Transfer Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Adoptive Cell Transfer Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Adoptive Cell Transfer Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Novartis AG Adoptive Cell Transfer Therapy Basic Information
Table 44. Novartis AG Adoptive Cell Transfer Therapy Product Overview
Table 45. Novartis AG Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Novartis AG Business Overview
Table 47. Novartis AG Adoptive Cell Transfer Therapy SWOT Analysis
Table 48. Novartis AG Recent Developments
Table 49. Kite Pharma Adoptive Cell Transfer Therapy Basic Information
Table 50. Kite Pharma Adoptive Cell Transfer Therapy Product Overview
Table 51. Kite Pharma Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Kite Pharma Business Overview
Table 53. Kite Pharma Adoptive Cell Transfer Therapy SWOT Analysis
Table 54. Kite Pharma Recent Developments
Table 55. Pfizer Adoptive Cell Transfer Therapy Basic Information
Table 56. Pfizer Adoptive Cell Transfer Therapy Product Overview
Table 57. Pfizer Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Pfizer Adoptive Cell Transfer Therapy SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Juno Therapeutics Adoptive Cell Transfer Therapy Basic Information
Table 62. Juno Therapeutics Adoptive Cell Transfer Therapy Product Overview
Table 63. Juno Therapeutics Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Juno Therapeutics Business Overview
Table 65. Juno Therapeutics Recent Developments
Table 66. Celgene Corporation Adoptive Cell Transfer Therapy Basic Information
Table 67. Celgene Corporation Adoptive Cell Transfer Therapy Product Overview
Table 68. Celgene Corporation Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Celgene Corporation Business Overview
Table 70. Celgene Corporation Recent Developments
Table 71. CARsgen Therapeutics Adoptive Cell Transfer Therapy Basic Information
Table 72. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Overview
Table 73. CARsgen Therapeutics Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. CARsgen Therapeutics Business Overview
Table 75. CARsgen Therapeutics Recent Developments
Table 76. Sorrento Therapeutics Adoptive Cell Transfer Therapy Basic Information
Table 77. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Overview
Table 78. Sorrento Therapeutics Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Sorrento Therapeutics Business Overview
Table 80. Sorrento Therapeutics Recent Developments
Table 81. Legend Biotech Adoptive Cell Transfer Therapy Basic Information
Table 82. Legend Biotech Adoptive Cell Transfer Therapy Product Overview
Table 83. Legend Biotech Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Legend Biotech Business Overview
Table 85. Legend Biotech Recent Developments
Table 86. Atara Biotherapeutics Adoptive Cell Transfer Therapy Basic Information
Table 87. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Overview
Table 88. Atara Biotherapeutics Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Atara Biotherapeutics Business Overview
Table 90. Atara Biotherapeutics Recent Developments
Table 91. Aurora Biopharma Adoptive Cell Transfer Therapy Basic Information
Table 92. Aurora Biopharma Adoptive Cell Transfer Therapy Product Overview
Table 93. Aurora Biopharma Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Aurora Biopharma Business Overview
Table 95. Aurora Biopharma Recent Developments
Table 96. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Basic Information
Table 97. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Overview
Table 98. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Autolus Therapeutics PLC Business Overview
Table 100. Autolus Therapeutics PLC Recent Developments
Table 101. Bluebird Adoptive Cell Transfer Therapy Basic Information
Table 102. Bluebird Adoptive Cell Transfer Therapy Product Overview
Table 103. Bluebird Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Bluebird Business Overview
Table 105. Bluebird Recent Developments
Table 106. Carina Biotech Adoptive Cell Transfer Therapy Basic Information
Table 107. Carina Biotech Adoptive Cell Transfer Therapy Product Overview
Table 108. Carina Biotech Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Carina Biotech Business Overview
Table 110. Carina Biotech Recent Developments
Table 111. Athenex Adoptive Cell Transfer Therapy Basic Information
Table 112. Athenex Adoptive Cell Transfer Therapy Product Overview
Table 113. Athenex Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Athenex Business Overview
Table 115. Athenex Recent Developments
Table 116. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Basic Information
Table 117. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Overview
Table 118. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
Table 120. Xiangxue Pharmaceutical (Xiangxue Precision) Recent Developments
Table 121. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Basic Information
Table 122. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Overview
Table 123. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Hengrui Yuanzheng Business Overview
Table 125. Hengrui Yuanzheng Recent Developments
Table 126. Eureka Therapeutics Adoptive Cell Transfer Therapy Basic Information
Table 127. Eureka Therapeutics Adoptive Cell Transfer Therapy Product Overview
Table 128. Eureka Therapeutics Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Eureka Therapeutics Business Overview
Table 130. Eureka Therapeutics Recent Developments
Table 131. WuXi Juno Adoptive Cell Transfer Therapy Basic Information
Table 132. WuXi Juno Adoptive Cell Transfer Therapy Product Overview
Table 133. WuXi Juno Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. WuXi Juno Business Overview
Table 135. WuXi Juno Recent Developments
Table 136. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Basic Information
Table 137. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Overview
Table 138. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Shenzhen Inno Immunity Business Overview
Table 140. Shenzhen Inno Immunity Recent Developments
Table 141. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Basic Information
Table 142. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Overview
Table 143. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Shenzhen Binde Bio Business Overview
Table 145. Shenzhen Binde Bio Recent Developments
Table 146. Kerui Bio Adoptive Cell Transfer Therapy Basic Information
Table 147. Kerui Bio Adoptive Cell Transfer Therapy Product Overview
Table 148. Kerui Bio Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Kerui Bio Business Overview
Table 150. Kerui Bio Recent Developments
Table 151. Adaptimmune Adoptive Cell Transfer Therapy Basic Information
Table 152. Adaptimmune Adoptive Cell Transfer Therapy Product Overview
Table 153. Adaptimmune Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Adaptimmune Business Overview
Table 155. Adaptimmune Recent Developments
Table 156. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Basic Information
Table 157. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Overview
Table 158. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Altor Bioscience Corporation Business Overview
Table 160. Altor Bioscience Corporation Recent Developments
Table 161. Cellectis Adoptive Cell Transfer Therapy Basic Information
Table 162. Cellectis Adoptive Cell Transfer Therapy Product Overview
Table 163. Cellectis Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Cellectis Business Overview
Table 165. Cellectis Recent Developments
Table 166. Takara Bio Adoptive Cell Transfer Therapy Basic Information
Table 167. Takara Bio Adoptive Cell Transfer Therapy Product Overview
Table 168. Takara Bio Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Takara Bio Business Overview
Table 170. Takara Bio Recent Developments
Table 171. Unum Therapeutics Adoptive Cell Transfer Therapy Basic Information
Table 172. Unum Therapeutics Adoptive Cell Transfer Therapy Product Overview
Table 173. Unum Therapeutics Adoptive Cell Transfer Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Unum Therapeutics Business Overview
Table 175. Unum Therapeutics Recent Developments
Table 176. Global Adoptive Cell Transfer Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 177. Global Adoptive Cell Transfer Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 178. North America Adoptive Cell Transfer Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 179. North America Adoptive Cell Transfer Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 180. Europe Adoptive Cell Transfer Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 181. Europe Adoptive Cell Transfer Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 182. Asia Pacific Adoptive Cell Transfer Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 183. Asia Pacific Adoptive Cell Transfer Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 184. South America Adoptive Cell Transfer Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 185. South America Adoptive Cell Transfer Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 186. Middle East and Africa Adoptive Cell Transfer Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 187. Middle East and Africa Adoptive Cell Transfer Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 188. Global Adoptive Cell Transfer Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 189. Global Adoptive Cell Transfer Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 190. Global Adoptive Cell Transfer Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 191. Global Adoptive Cell Transfer Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 192. Global Adoptive Cell Transfer Therapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Adoptive Cell Transfer Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adoptive Cell Transfer Therapy Market Size (M USD), 2019-2030
Figure 5. Global Adoptive Cell Transfer Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Adoptive Cell Transfer Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Adoptive Cell Transfer Therapy Market Size by Country (M USD)
Figure 11. Adoptive Cell Transfer Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Adoptive Cell Transfer Therapy Revenue Share by Manufacturers in 2023
Figure 13. Adoptive Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Adoptive Cell Transfer Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Adoptive Cell Transfer Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Adoptive Cell Transfer Therapy Market Share by Type
Figure 18. Sales Market Share of Adoptive Cell Transfer Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Adoptive Cell Transfer Therapy by Type in 2023
Figure 20. Market Size Share of Adoptive Cell Transfer Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Adoptive Cell Transfer Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Adoptive Cell Transfer Therapy Market Share by Application
Figure 24. Global Adoptive Cell Transfer Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Adoptive Cell Transfer Therapy Sales Market Share by Application in 2023
Figure 26. Global Adoptive Cell Transfer Therapy Market Share by Application (2019-2024)
Figure 27. Global Adoptive Cell Transfer Therapy Market Share by Application in 2023
Figure 28. Global Adoptive Cell Transfer Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Adoptive Cell Transfer Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Adoptive Cell Transfer Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Adoptive Cell Transfer Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Adoptive Cell Transfer Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Adoptive Cell Transfer Therapy Sales Market Share by Country in 2023
Figure 37. Germany Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Adoptive Cell Transfer Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Adoptive Cell Transfer Therapy Sales Market Share by Region in 2023
Figure 44. China Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Adoptive Cell Transfer Therapy Sales and Growth Rate (K Units)
Figure 50. South America Adoptive Cell Transfer Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Adoptive Cell Transfer Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Adoptive Cell Transfer Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Adoptive Cell Transfer Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Adoptive Cell Transfer Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Adoptive Cell Transfer Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Adoptive Cell Transfer Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Adoptive Cell Transfer Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Adoptive Cell Transfer Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Adoptive Cell Transfer Therapy Market Share Forecast by Application (2025-2030)
